WAVE Life Sciences (WVE) Misses Q2 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Jones Trading Starts WAVE Life Sciences (WVE) at Buy
August 8, 2024 4:06 PM EDTJones Trading analyst Catherine Novack initiates coverage on WAVE Life Sciences (NASDAQ: WVE) with a Buy rating and a price target of $12.00.
The analyst comments "We are initiating coverage of Wave Life Sciences with a BUY rating and $12 price target. WVE's portfolio contains... More
